Vertex Pharmaceuticals
Colleen O'Brien has an extensive background in toxicology research and preclinical safety assessment, with experience in various roles at Vertex Pharmaceuticals, Elixir Pharmaceuticals, Toxikon Corporation, Charles River Laboratories, Biomedical Research Models Inc., Clark University, and UMass Medical School. Colleen holds a Bachelor's degree in Biology from Clark University.
Vertex Pharmaceuticals
87 followers
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.